Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$1.93B |
| 2 |
Texas Instruments
TXN
|
+$1.78B |
| 3 |
NVIDIA
NVDA
|
+$1.66B |
| 4 |
Starbucks
SBUX
|
+$1.15B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$974M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.13B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.32B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.13B |
| 5 |
Procter & Gamble
PG
|
+$923M |
Sector Composition
| 1 | Technology | 33.53% |
| 2 | Consumer Discretionary | 10.88% |
| 3 | Financials | 10.79% |
| 4 | Communication Services | 9.25% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Day One Biopharmaceuticals
DAWN
$729M
| $765K | ﹤0.01% |
55,594
-11,872
| -18% | -$163K |
|
2177
Fortis
FTS
$24.9B
| $765K | ﹤0.01% |
19,681
+3,170
| +19% | +$123K |
|
2178
Viridian Therapeutics
VRDN
$1.54B
| $765K | ﹤0.01% |
58,847
-65,301
| -53% | -$849K |
|
2179
Universal Insurance Holdings
UVE
$719M
| $763K | ﹤0.01% |
40,691
-7,218
| -15% | -$135K |
|
2180
Steelcase
SCS
$1.93B
| $761K | ﹤0.01% |
58,734
-47,651
| -45% | -$617K |
|
2181
Karyopharm Therapeutics
KPTI
$55.9M
| $758K | ﹤0.01% |
58,218
-1,303
| -2% | -$17K |
|
2182
Liberty Live Group Series A
LLYVA
$8.95B
| $758K | ﹤0.01% |
20,197
-22,869
| -53% | -$858K |
|
|
CMBT
2183
CMB.TECH NV
CMBT
$2.8B
| $757K | ﹤0.01% |
45,758
-221,835
| -83% | -$3.67M |
|
2184
PMV Pharmaceuticals
PMVP
$65.2M
| $753K | ﹤0.01% |
464,952
-28,598
| -6% | -$46.3K |
|
2185
Relay Therapeutics
RLAY
$688M
| $752K | ﹤0.01% |
115,278
-24,718
| -18% | -$161K |
|
2186
1-800-Flowers.com
FLWS
$343M
| $750K | ﹤0.01% |
78,754
+9,652
| +14% | +$91.9K |
|
2187
Mersana Therapeutics
MRSN
$35.6M
| $750K | ﹤0.01% |
14,909
-1,460
| -9% | -$73.4K |
|
|
GMRE
2188
Global Medical REIT
GMRE
$512M
| $749K | ﹤0.01% |
82,347
+27,333
| +50% | +$249K |
|
2189
Ethan Allen Interiors
ETD
$742M
| $746K | ﹤0.01% |
26,737
-13,872
| -34% | -$387K |
|
2190
Leslie's
LESL
$62M
| $743K | ﹤0.01% |
177,360
-93,462
| -35% | -$392K |
|
2191
QCR Holdings
QCRH
$1.3B
| $743K | ﹤0.01% |
12,375
-9,405
| -43% | -$565K |
|
2192
Mobileye
MBLY
$11.1B
| $740K | ﹤0.01% |
26,352
-4,791
| -15% | -$135K |
|
2193
Ooma
OOMA
$345M
| $739K | ﹤0.01% |
74,562
+3,747
| +5% | +$37.1K |
|
2194
First Foundation Inc
FFWM
$493M
| $736K | ﹤0.01% |
112,266
-116,326
| -51% | -$763K |
|
2195
Nicolet Bankshares
NIC
$2B
| $736K | ﹤0.01% |
8,857
-8,139
| -48% | -$676K |
|
2196
The RMR Group
RMR
$288M
| $736K | ﹤0.01% |
32,574
-7,479
| -19% | -$169K |
|
2197
SpartanNash
SPTN
$897M
| $736K | ﹤0.01% |
39,271
-22,765
| -37% | -$427K |
|
2198
Kimball Electronics
KE
$741M
| $735K | ﹤0.01% |
33,478
-12,721
| -28% | -$279K |
|
2199
Portillo's
PTLO
$441M
| $734K | ﹤0.01% |
75,486
-9,549
| -11% | -$92.9K |
|
2200
Integra LifeSciences
IART
$1.17B
| $733K | ﹤0.01% |
25,167
-49,076
| -66% | -$1.43M |
|